Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03052972 · ClinicalTrials.gov registry record · Phase 1
Flortaucipir 18F PET Imaging in BIOCARD Study
A Phase 1 study, sponsored by Avid Radiopharmaceuticals.
- Terminated
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT03052972 is a Phase 1 study that was terminated before completion, run by Avid Radiopharmaceuticals. The registered enrollment target is 23 participants.
The verdict
NCT03052972, a Phase 1 study, was terminated before completion, sponsored by Avid Radiopharmaceuticals.
- TERMINATED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
This study is designed to assess the imaging characteristics of Flortaucipir (18F-AV-1451) in subjects who participated in the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study at Johns Hopkins University.
Interventions
- DRUG Flortaucipir F18
- PROCEDURE Brain PET scan
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2017-03-23 |
| Est. Completion | 2018-08-17 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03052972
The ClinicalTrials.gov registry entry for NCT03052972 describes a study currently listed as terminated, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Avid Radiopharmaceuticals, which has 42 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Flortaucipir F18 is the first listed.
NCT03052972 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03052972 about?
NCT03052972 is a clinical study titled "Flortaucipir 18F PET Imaging in BIOCARD Study". This study is designed to assess the imaging characteristics of Flortaucipir (18F-AV-1451) in subjects who participated in the Biomarkers of Cognitive Decline Among Normal Individuals (BIOCARD) study at Johns Hopkins University.
What is the current status of trial NCT03052972?
This trial is currently terminated. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2017-03-23. Estimated completion is 2018-08-17.
What interventions are being tested in trial NCT03052972?
The interventions under investigation include: Flortaucipir F18 (DRUG), Brain PET scan (PROCEDURE).
Who is sponsoring clinical trial NCT03052972?
This trial is sponsored by Avid Radiopharmaceuticals, which has 42 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.